Our Team
Our project brings together two core teams: our research team, which drives scientific innovation and assay development, and our commercialization team, which ensures our technology translates effectively into real-world applications. Together, we bridge cutting-edge diagnostic science with entrepreneurial execution to bring a new era of precision hormone testing to both clinics and homes.
Science Meets Strategy
Here are the people behind ICDx — molecular biologists, assay developers, and commercialization specialists — working side by side to redefine what hormone diagnostics can achieve. United by a shared vision, we are transforming high-affinity immunocomplex antibody technology into accessible, market-ready tools for personalized healthcare.
Commercialization Team
Our commercialization team combines scientific leadership with business development expertise to bring ICDx technology from the lab to the market. Led by the project’s principal investigator and supported by experienced business developers and researchers, this team drives strategic planning, market validation, and commercial readiness — ensuring our innovation is positioned for real-world impact and investment.
Janne Leivo (Ph.D., Adj.Prof.)
Principal Investigator
Teppo Hyytiä
Senior Business Development Manager
Ida Bäckström
Doctoral Researcher
Irene Callus
Project Researcher